From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
We explore today's headlines about new US research on immunotherapy for blood cancers.
We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer.
We explore the promise and challenges of research looking to engineer patients' immune cells to fight cancer.
We caught up with Professor Richard Gilbertson to find out the challenges facing research into children’s cancers, and where the field is heading.
On the final day of the conference the media picked up on two studies. The first found that across a poll of almost 1,500 people many were unaware of the full purpose of...
After decades in the shadows, treatments that encourage a patient’s own immune system to target their cancer – known as immunotherapy – have emerged as one of the...